For the quarter ending 2026-03-31, BIIB has $29,483,100K in assets. $10,831,400K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,382,700 | 3,008,500 | 3,862,800 | 2,758,800 |
| Current portion of marketable securities | 900,000 | 807,200 | 97,600 | - |
| Accounts receivable, net of allowance for doubtful accounts of 3.0 and 2.2, respectively | - | 1,342,400 | - | - |
| Accounts receivable, net of allowance for doubtful accounts of 3.0 and 3.0, respectively-Nonrelated Party | 1,369,200 | - | 1,374,100 | 1,624,200 |
| Due from anti-cd20 therapeutic programs | - | 524,600 | - | - |
| Accounts receivable, net of allowance for doubtful accounts of 3.0 and 3.0, respectively-Related Party | 421,200 | - | 475,900 | 459,800 |
| Inventory | 1,949,000 | 2,168,100 | 2,209,400 | 2,274,300 |
| Other current assets | 1,168,300 | 1,123,300 | 916,800 | 850,600 |
| Total current assets | 9,190,400 | 8,974,100 | 8,936,600 | 7,967,700 |
| Marketable securities | 465,600 | 431,900 | - | - |
| Property, plant and equipment, net | 3,017,900 | 3,055,400 | 3,075,700 | 3,098,800 |
| Operating lease assets | 251,300 | 265,400 | 330,500 | 334,500 |
| Intangible assets, net | 9,053,500 | 9,178,500 | 9,331,900 | 9,467,500 |
| Goodwill | 6,488,700 | 6,491,100 | 6,490,700 | 6,493,100 |
| Deferred tax asset | 238,200 | 292,500 | 312,400 | 330,900 |
| Investments and other assets | 777,500 | 750,600 | 729,700 | 637,700 |
| Total assets | 29,483,100 | 29,439,500 | 29,207,500 | 28,330,200 |
| Current portion of notes payable | - | 0 | 0 | 0 |
| Taxes payable | 93,600 | 114,800 | 103,300 | 114,800 |
| Accounts payable | 358,500 | 432,000 | 413,100 | 408,400 |
| Accrued expense and other | 2,546,800 | 2,802,600 | 2,773,600 | 2,660,500 |
| Total current liabilities | 2,998,900 | 3,349,400 | 3,290,000 | 3,183,700 |
| Notes payable | 6,288,500 | 6,286,800 | 6,285,100 | 6,283,700 |
| Deferred tax liability | 483,500 | 507,600 | 358,100 | 118,300 |
| Long-term operating lease liabilities | 273,400 | 290,400 | 305,000 | 310,900 |
| Other long-term liabilities | 787,100 | 748,500 | 761,800 | 799,600 |
| Total liabilities | 10,831,400 | 11,182,700 | 11,000,000 | 10,696,200 |
| Common stock, par value 0.0005 per share | 100 | 100 | 100 | 100 |
| Additional paid-in capital | 896,700 | 863,100 | 797,700 | 714,000 |
| Accumulated other comprehensive income (loss) | -140,200 | -182,000 | -214,800 | -238,100 |
| Retained earnings | 20,872,200 | 20,552,700 | 20,601,600 | 20,135,100 |
| Treasury stock, at cost | 2,977,100 | 2,977,100 | 2,977,100 | 2,977,100 |
| Total equity | 18,651,700 | 18,256,800 | 18,207,500 | 17,634,000 |
| Total liabilities and equity | 29,483,100 | 29,439,500 | 29,207,500 | 28,330,200 |
BIOGEN INC. (BIIB)
BIOGEN INC. (BIIB)